We are monitoring the impact of COVID-19 on Breast Biopsy Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 4101
Share on
Share on

Global Breast Biopsy Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Type, Product, Guidance & Region - Industry Forecast (2021 to 2026)

Pulished: April, 2021
ID: 4101
Pages: 175

Global Breast Biopsy Market Size (2021 to 2026)

The global breast biopsy market size is predicted to grow USD 1104.89 Million by 2026 from USD 658.36 million in 2021, growing at a CAGR of 10.91% during the forecast period.

A breast biopsy is a test performed to remove tissue or fluid from a diseased area of the patient’s body, while the extracted sample is further examined to check the presence of breast cancer. There are different types of biopsy procedures depending on the product, such as vacuum-assisted biopsy (VAB), core needle biopsy (CNB), and fine-needle aspiration biopsy (FNAB), recommended by the doctor based on the location, size, and other characteristics of the breast abnormality. The various techniques of the biopsy market work quickly, and it is simple. As a result, the results are fast and accurate.

MARKET DRIVERS:

Y-O-Y growth in the incidence of breast cancer is primarily driving the global breast biopsy market growth.

An increase in breast cancer incidence in women, especially around the age of 40, and growth in awareness regarding breast cancer screening programs drive the market growth. According to the statistics of nationalbreastcancer.org, United States had an estimated new 276,480 invasive and 48,530 non-invasive breast cancer cases in 2020. They further stated that 1 in every 8 women are likely to develop breast cancer in their lifetime in the United States.

The emergence of technologically advanced and minimally invasive breast biopsy devices is expected to provide these untapped market opportunities. Growing awareness regarding breast biopsy across the world and the increasing geriatric ladies' populace are further expected to add a boost to the growth rate of the breast biopsy market.

MARKET RESTRAINTS:

The restraints in this market include the high cost of procedure and demand skewed towards a specific gender and middle age to the elderly age group, eliminating a significant chunk of the population segment. In addition, the risk of infection due to improper care of breast biopsy cuts and wounds and uncertain regulatory guidelines for medical devices are likely to limit the growth of the global breast biopsy market.

Impact of COVID-19 on the global breast biopsy market:

The COVID-19 has affected so many sectors differently. The COVID-19 is declared as a pandemic by World Health Organisation (WHO). The global economy was drastically decreased due to the coronavirus. Lockdown has influenced so many industries in several ways, where some industries got impacted badly, some gained profits. The Breast Biopsy Market is not an exception. The Global Breast Biopsy Market has gone through some rough times during the pandemic. Due to lockdown, the patient flow has slowed down since the restricted access to clinics and hospitals, which affected the Breast Biopsy Market. The fear in people about COVID 19 dragged people from getting diagnoses during the pandemic. Moreover, the breast biopsy devices required for breast biopsy treatment had not been delivered to the hospitals due to the pandemic, which hammered the market. But, after the pandemic, the market is getting profits. The key players in the market are introducing new devices like Ultrasound Guided Breast Biopsy Devices to sustain the market competition.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2020 to 2026

Base Year

2020

Forecast Period

2021 to 2026

Segments Covered

By Product, Type, Guidance, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This market research report on the global breast biopsy market has been segmented and sub-segmented based on the product, type, guidance, and region.

Breast Biopsy Market – By Product:

  • Biopsy needles      
  • Guidance systems               
  • Biopsy tables          
  • Localization wires 
  • Others      

The biopsy needles had held the major market share based on the product and are estimated to grow at a CAGR of 12.1% during the forecast period. The rapid rise in the adoption of Biopsy needles in hospitals and clinics due to its advantages, like high sensitivity and specificity, drives the Biopsy needle segment. In addition, the advancements in technological devices are boosting the market. For example, Stryker PreciseCore needles allow sample acquisition with higher precision and considerably more negligible tissue damage risks. Moreover, the Biopsy Needles more accurate assessment of breast mass than fine-needle aspiration. Therefore, the Guidance Systems segment is predominantly rising during the forecast period.

Breast Biopsy Market – By Type:

  • Needle Breast Biopsy         
    • Core Needle Biopsy
    • Fine Needle Aspiration Biopsy
    • Vacuum-Assisted Biopsy
  • Open Surgical Breast Biopsy             
    • Excisional Breast Biopsy
    • Incisional Breast Biopsy

Based on type, Vacuum-assisted biopsy accounts for a significant portion of the revenue. These devices can accurately locate the abnormality area without any difficulties, and the less-invasive nature of this technique is driving the vacuum-assisted biopsy segment. The increase in usage of vacuum-assisted biopsy is boosting the segment. The Fine Needle Aspiration Biopsy is significantly growing during the forecast period. The growth in the demand for minimally invasive procedures and technological devices' advancements drives the Needle Aspiration Biopsy segment.

Breast Biopsy Market – By Guidance:

  • Mammography-Guided Stereotactic Breast Biopsy
  • Ultrasound-Guided Breast Biopsy
  • MRI-Guided Breast Biopsy
  • Other Guidance Techniques

Based on guidance, the ultrasound segment is expected to be the fastest-growing segment. It is the fastest technique among all, which is driving the Ultrasound-Guided Breast Biopsy segment. It also decreases the need for ionizing radiation exposure and is opposite to the conventional mammography-guided stereotactic biopsy procedure. These are the factors boosting the Ultrasound-Guided Breast Biopsy segment growth. As a result, the mammography-guided segment is estimated to grow at the highest CAGR during the forecast period. 

Breast Biopsy Market – By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Geographically, the global breast biopsy market was dominated by North America, followed by Europe in 2020. Asia Pacific is expected to grow at the highest CAGR. During the forecast period, the North American Breast Biopsy Market size is forecasted to be growing at a CAGR of 10.5% due to the growing incidence of breast cancer in this region and the quick adoption of technological advancements. In this region, the United States market is predicted to account majority share during the forecast period. Breast cancer awareness is significantly growing in the U.S., and the ongoing technological advancements in the treatment options are expected to fuel the U.S. breast biopsy market during the forecast period. On the other end, the Canadian market is projected to rise at a lucrative growth rate during the forecast period.

Europe was the second-largest regional market globally in 2020 and was worth USD 126.55 million in 2021. Countries like the U.K. and Germany are expected to have lucrative growth opportunities during the forecast period in this regional market.

The Asia-Pacific market is forecasted to be the fastest-growing region in the global market during the forecast period. Across the globe, Asia has the highest percentage of an aging population. A significant spike has been noticed in the breast cancer incidence in this region in the recent past, which is expected to drive this regional market during the forecast period.

The Latin American Breast Biopsy market is predicted to be worth USD 89.87 million by 2026. In this region, countries like Brazil and Mexico are projected to grow significantly during the forecast period.

KEY MARKET PARTICIPANTS:

The list of key players included in the report includes Hologic Inc., Leica Biosystems Nussloch GmbH (Devicor Medical Products, Inc.), C. R. Bard, Inc., Becton and Dickinson Company, Argon Medical Devices, Cook Medical Incorporated, Encapsule medical Devices LLC., Ethicon Endo-Surgery (Johnson & Johnson), Intact Medical Corporation, and Galini SRL.

RECENT MARKET DEVELOPMENTS:

  • Hologic's Brevera Breast Biopsy System with CorLumina Imaging Technology gained European CE mark clearance in 2018. This technology enhances biopsy accuracy, patient satisfaction, and workflow in the biopsy suite with real-time imaging.
  • Hologic announced introducing their CorLumina Imaging Technology Brevera breast biopsy system for commercial access in the United States in 2017. It is developed with real-time imaging to boost the accuracy of the biopsy, improve patient experience and simplify the biopsy from start to end.
  • Mayo Clinic and Imago Systems Image Visualization Company cooperated on Breast Imaging in August 2019.
  • Dune Medical Devices announced the first in man test of their smart biopsy instrument in March 2019. Dune Medical's Smart Biopsy is a percutaneous soft tissue biopsy tool that uses tiny key needle detectors to provide real-time electrical samples. To improve diagnosis and readout, these electrical pulses are compared to histological data. The in-man stage marks the commencement of a larger, more thorough clinical study aimed at determining the specific tissue composition of the breast.
  • C. R. Bard Inc. was purchased by Becton, Dickinson, and Company (BD) for $16.0 billion. The merged firm is anticipated to focus on enhancing illness treatment and providing more convenience to healthcare professionals. Furthermore, C.R. Bard's robust product portfolio and innovation pipeline will expand BD's potential in fast-growing clinical areas and expand the combined company's growth opportunities outside of the United States.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Introduction           

                                5.1.2 Biopsy needles      

                                5.1.3 Guidance systems               

                                5.1.4 Biopsy tables          

                                5.1.5 Localization wires 

                                5.1.6 Others      

                                5.1.7  Y-o-Y Growth Analysis, By Product              

                                5.1.8  Market Attractiveness Analysis, By Product            

                                5.1.9  Market Share Analysis, By Product              

                5.2 Type                              

                                5.2.1 Introduction           

                                5.2.2 Needle breast biopsy         

                                                5.2.2.1 Core needle biopsy

                                                5.2.2.2 Fine needle aspiration biopsy

                                                5.2.2.3 Vacuum assisted biopsy

                                5.2.3 Open surgical breast biopsy             

                                                5.2.3.1 Excisional breast biopsy

                                                5.2.3.2 Incisional breast biopsy

                                5.2.4 Y-o-Y Growth Analysis, By Type     

                                5.2.5 Market Attractiveness Analysis, By Type   

                                5.2.6 Market Share Analysis, By Type     

                5.3 Guidance                     

                                5.3.1 Introduction           

                                5.3.2 Mammography-Guided Stereotactic Breast Biopsy               

                                5.3.3 Ultrasound-Guided Breast Biopsy 

                                5.3.4 MRI-Guided Breast Biopsy               

                                5.3.5 Other Guidance Techniques            

                                5.3.6 Y-o-Y Growth Analysis, By Application         

                                5.3.7  Market Attractiveness Analysis, By Application      

                                5.3.8  Market Share Analysis, By Application       

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By Type

                                                6.1.3.4 By Guidance

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By Type

                                                6.1.4.4 By Guidance

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By Type

                                                6.1.5.4 By Guidance

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1  Hologic Inc.                

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Leica Biosystems Nussloch GmbH                     

                8.3 C. R. Bard Inc.                            

                8.4 Becton and Dickinson Company                        

                8.5 Argon Medical Devices                          

                8.6 Cook Medical Incorporated                 

                8.7 Encapsule medical Devices LLC.                         

                8.8 Ethicon Endo Surgery                             

                8.9 Intact Medical Corporation                  

                8.10 Galini SRL                  

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms of product, type and guidance along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Breast Biopsy Market, By Region, From 2021 to 2026 (USD Million)
  2. Global Breast Biopsy Market, By Product, From 2021 to 2026 (USD Million)
  3. Global Biopsy needles Market, By Region, From 2021 to 2026 (USD Million)
  4. Global Guidance systems Market, By Region, From 2021 to 2026 (USD Million)
  5. Global Biopsy tables Market, By Region, From 2021 to 2026 (USD Million)
  6. Global Localization wires Market, By Region, From 2021 to 2026 (USD Million)
  7. Global Others Market, By Region, From 2021 to 2026 (USD Million)
  8. Global Breast Biopsy Market, By Type, From 2021 to 2026 (USD Million)
  9. Global Needle breast biopsy Market, By Region, From 2021 to 2026 (USD Million)
  10. Global Open surgical breast biopsy Market, By Region, From 2021 to 2026 (USD Million)
  11. Global Breast Biopsy Market, By Guidance, From 2021 to 2026 (USD Million)
  12. Global Mammography-Guided Stereotactic Breast Biopsy Market, By Region, From 2021 to 2026 (USD Million)
  13. Global Ultrasound-Guided Breast Biopsy Market, By Region, From 2021 to 2026 (USD Million)
  14. Global MRI-Guided Breast Biopsy Market, By Region, From 2021 to 2026 (USD Million)
  15. Global Other Guidance Techniques Market, By Region, From 2021 to 2026 (USD Million)
  16. North America Breast Biopsy Market, By Product, From 2021 to 2026 (USD Million)
  17. North America Biopsy needles Market, By Region, From 2021 to 2026 (USD Million)
  18. North America Guidance systems Market, By Region, From 2021 to 2026 (USD Million)
  19. North America Biopsy tables Market, By Region, From 2021 to 2026 (USD Million)
  20. North America Localization wires Market, By Region, From 2021 to 2026 (USD Million)
  21. North America Others Market, By Region, From 2021 to 2026 (USD Million)
  22. North America Breast Biopsy Market, By Type, From 2021 to 2026 (USD Million)
  23. North America Needle breast biopsy Market, By Region, From 2021 to 2026 (USD Million)
  24. North America Open surgical breast biopsy Market, By Region, From 2021 to 2026 (USD Million)
  25. North America Breast Biopsy Market, By Guidance, From 2021 to 2026 (USD Million)
  26. North America Mammography-Guided Stereotactic Breast Biopsy Market, By Region, From 2021 to 2026 (USD Million)
  27. North America Ultrasound-Guided Breast Biopsy Market, By Region, From 2021 to 2026 (USD Million)
  28. North America MRI-Guided Breast Biopsy Market, By Region, From 2021 to 2026 (USD Million)
  29. North America Other Guidance Techniques Market, By Region, From 2021 to 2026 (USD Million)
  30. United States Breast Biopsy Market, By Product, From 2021 to 2026 (USD Million)
  31. United States Breast Biopsy Market, By Type, From 2021 to 2026 (USD Million)
  32. United States Breast Biopsy Market, By Guidance, From 2021 to 2026 (USD Million)
  33. Canada Breast Biopsy Market, By Product, From 2021 to 2026 (USD Million)
  34. Canada Breast Biopsy Market, By Type, From 2021 to 2026 (USD Million)
  35. Canada Breast Biopsy Market, By Guidance, From 2021 to 2026 (USD Million)
  36. Europe Breast Biopsy Market, By Product, From 2021 to 2026 (USD Million)
  37. Europe Biopsy needles Market, By Region, From 2021 to 2026 (USD Million)
  38. Europe Guidance systems Market, By Region, From 2021 to 2026 (USD Million)
  39. Europe Biopsy tables Market, By Region, From 2021 to 2026 (USD Million)
  40. Europe Localization wires Market, By Region, From 2021 to 2026 (USD Million)
  41. Europe Others Market, By Region, From 2021 to 2026 (USD Million)
  42. Europe Breast Biopsy Market, By Type, From 2021 to 2026 (USD Million)
  43. Europe Needle breast biopsy Market, By Region, From 2021 to 2026 (USD Million)
  44. Europe Open surgical breast biopsy Market, By Region, From 2021 to 2026 (USD Million)
  45. Europe Breast Biopsy Market, By Guidance, From 2021 to 2026 (USD Million)
  46. Europe Mammography-Guided Stereotactic Breast Biopsy Market, By Region, From 2021 to 2026 (USD Million)
  47. Europe Ultrasound-Guided Breast Biopsy Market, By Region, From 2021 to 2026 (USD Million)
  48. Europe MRI-Guided Breast Biopsy Market, By Region, From 2021 to 2026 (USD Million)
  49. Europe Other Guidance Techniques Market, By Region, From 2021 to 2026 (USD Million)
  50. U.K. Breast Biopsy Market, By Product, From 2021 to 2026 (USD Million)
  51. U.K. Breast Biopsy Market, By Type, From 2021 to 2026 (USD Million)
  52. U.K. Breast Biopsy Market, By Guidance, From 2021 to 2026 (USD Million)
  53. Germany Breast Biopsy Market, By Product, From 2021 to 2026 (USD Million)
  54. Germany Breast Biopsy Market, By Type, From 2021 to 2026 (USD Million)
  55. Germany Breast Biopsy Market, By Guidance, From 2021 to 2026 (USD Million)
  56. France Breast Biopsy Market, By Product, From 2021 to 2026 (USD Million)
  57. France Breast Biopsy Market, By Type, From 2021 to 2026 (USD Million)
  58. France Breast Biopsy Market, By Guidance, From 2021 to 2026 (USD Million)
  59. Italy Breast Biopsy Market, By Product, From 2021 to 2026 (USD Million)
  60. Italy Breast Biopsy Market, By Type, From 2021 to 2026 (USD Million)
  61. Italy Breast Biopsy Market, By Guidance, From 2021 to 2026 (USD Million)
  62. Spain Breast Biopsy Market, By Product, From 2021 to 2026 (USD Million)
  63. Spain Breast Biopsy Market, By Type, From 2021 to 2026 (USD Million)
  64. Spain Breast Biopsy Market, By Guidance, From 2021 to 2026 (USD Million)
  65. Asia Pacific Breast Biopsy Market, By Product, From 2021 to 2026 (USD Million)
  66. Asia Pacific Biopsy needles Market, By Region, From 2021 to 2026 (USD Million)
  67. Asia Pacific Guidance systems Market, By Region, From 2021 to 2026 (USD Million)
  68. Asia Pacific Biopsy tables Market, By Region, From 2021 to 2026 (USD Million)
  69. Asia Pacific Localization wires Market, By Region, From 2021 to 2026 (USD Million)
  70. Asia Pacific Others Market, By Region, From 2021 to 2026 (USD Million)
  71. Asia Pacific Breast Biopsy Market, By Type, From 2021 to 2026 (USD Million)
  72. Asia Pacific Needle breast biopsy Market, By Region, From 2021 to 2026 (USD Million)
  73. Asia Pacific Open surgical breast biopsy Market, By Region, From 2021 to 2026 (USD Million)
  74. Asia Pacific Breast Biopsy Market, By Guidance, From 2021 to 2026 (USD Million)
  75. Asia Pacific Mammography-Guided Stereotactic Breast Biopsy Market, By Region, From 2021 to 2026 (USD Million)
  76. Asia Pacific Ultrasound-Guided Breast Biopsy Market, By Region, From 2021 to 2026 (USD Million)
  77. Asia Pacific MRI-Guided Breast Biopsy Market, By Region, From 2021 to 2026 (USD Million)
  78. Asia Pacific Other Guidance Techniques Market, By Region, From 2021 to 2026 (USD Million)
  79. Japan Breast Biopsy Market, By Product, From 2021 to 2026 (USD Million)
  80. Japan Breast Biopsy Market, By Type, From 2021 to 2026 (USD Million)
  81. Japan Breast Biopsy Market, By Guidance, From 2021 to 2026 (USD Million)
  82. China Breast Biopsy Market, By Product, From 2021 to 2026 (USD Million)
  83. China Breast Biopsy Market, By Type, From 2021 to 2026 (USD Million)
  84. China Breast Biopsy Market, By Guidance, From 2021 to 2026 (USD Million)
  85. India Breast Biopsy Market, By Product, From 2021 to 2026 (USD Million)
  86. India Breast Biopsy Market, By Type, From 2021 to 2026 (USD Million)
  87. India Breast Biopsy Market, By Guidance, From 2021 to 2026 (USD Million)
  88. Australia Breast Biopsy Market, By Product, From 2021 to 2026 (USD Million)
  89. Australia Breast Biopsy Market, By Type, From 2021 to 2026 (USD Million)
  90. Australia Breast Biopsy Market, By Guidance, From 2021 to 2026 (USD Million)
  91. South Korea Breast Biopsy Market, By Product, From 2021 to 2026 (USD Million)
  92. South Korea Breast Biopsy Market, By Type, From 2021 to 2026 (USD Million)
  93. South Korea Breast Biopsy Market, By Guidance, From 2021 to 2026 (USD Million)
  94. Latin America Breast Biopsy Market, By Product, From 2021 to 2026 (USD Million)
  95. Latin America Biopsy needles Market, By Region, From 2021 to 2026 (USD Million)
  96. Latin America Guidance systems Market, By Region, From 2021 to 2026 (USD Million)
  97. Latin America Biopsy tables Market, By Region, From 2021 to 2026 (USD Million)
  98. Latin America Localization wires Market, By Region, From 2021 to 2026 (USD Million)
  99. Latin America Others Market, By Region, From 2021 to 2026 (USD Million)
  100. Latin America Breast Biopsy Market, By Type, From 2021 to 2026 (USD Million)
  101. Latin America Needle breast biopsy Market, By Region, From 2021 to 2026 (USD Million)
  102. Latin America Open surgical breast biopsy Market, By Region, From 2021 to 2026 (USD Million)
  103. Latin America Breast Biopsy Market, By Guidance, From 2021 to 2026 (USD Million)
  104. Latin America Mammography-Guided Stereotactic Breast Biopsy Market, By Region, From 2021 to 2026 (USD Million)
  105. Latin America Ultrasound-Guided Breast Biopsy Market, By Region, From 2021 to 2026 (USD Million)
  106. Latin America MRI-Guided Breast Biopsy Market, By Region, From 2021 to 2026 (USD Million)
  107. Latin America Other Guidance Techniques Market, By Region, From 2021 to 2026 (USD Million)
  108. Brazil Breast Biopsy Market, By Product, From 2021 to 2026 (USD Million)
  109. Brazil Breast Biopsy Market, By Type, From 2021 to 2026 (USD Million)
  110. Brazil Breast Biopsy Market, By Guidance, From 2021 to 2026 (USD Million)
  111. Argentina Breast Biopsy Market, By Product, From 2021 to 2026 (USD Million)
  112. Argentina Breast Biopsy Market, By Type, From 2021 to 2026 (USD Million)
  113. Argentina Breast Biopsy Market, By Guidance, From 2021 to 2026 (USD Million)
  114. Mexico Breast Biopsy Market, By Product, From 2021 to 2026 (USD Million)
  115. Mexico Breast Biopsy Market, By Type, From 2021 to 2026 (USD Million)
  116. Mexico Breast Biopsy Market, By Guidance, From 2021 to 2026 (USD Million)
  117. Rest of Latin America Breast Biopsy Market, By Product, From 2021 to 2026 (USD Million)
  118. Rest of Latin America Breast Biopsy Market, By Type, From 2021 to 2026 (USD Million)
  119. Rest of Latin America Breast Biopsy Market, By Guidance, From 2021 to 2026 (USD Million)
  120. Middle East and Africa Breast Biopsy Market, By Product, From 2021 to 2026 (USD Million)
  121. Middle East and Africa Biopsy needles Market, By Region, From 2021 to 2026 (USD Million)
  122. Middle East and Africa Guidance systems Market, By Region, From 2021 to 2026 (USD Million)
  123. Middle East and Africa Biopsy tables Market, By Region, From 2021 to 2026 (USD Million)
  124. Middle East and Africa Localization wires Market, By Region, From 2021 to 2026 (USD Million)
  125. Middle East and Africa Others Market, By Region, From 2021 to 2026 (USD Million)
  126. Middle East and Africa Breast Biopsy Market, By Type, From 2021 to 2026 (USD Million)
  127. Middle East and Africa Needle breast biopsy Market, By Region, From 2021 to 2026 (USD Million)
  128. Middle East and Africa Open surgical breast biopsy Market, By Region, From 2021 to 2026 (USD Million)
  129. Middle East and Africa Breast Biopsy Market, By Guidance, From 2021 to 2026 (USD Million)
  130. Middle East and Africa Mammography-Guided Stereotactic Breast Biopsy Market, By Region, From 2021 to 2026 (USD Million)
  131. Middle East and Africa Ultrasound-Guided Breast Biopsy Market, By Region, From 2021 to 2026 (USD Million)
  132. Middle East and Africa MRI-Guided Breast Biopsy Market, By Region, From 2021 to 2026 (USD Million)
  133. Middle East and Africa Other Guidance Techniques Market, By Region, From 2021 to 2026 (USD Million)
  134. Middle East Breast Biopsy Market, By Product, From 2021 to 2026 (USD Million)
  135. Middle East Breast Biopsy Market, By Type, From 2021 to 2026 (USD Million)
  136. Middle East Breast Biopsy Market, By Guidance, From 2021 to 2026 (USD Million)
  137. Africa Breast Biopsy Market, By Product, From 2021 to 2026 (USD Million)
  138. Africa Breast Biopsy Market, By Type, From 2021 to 2026 (USD Million)
  139. Africa Breast Biopsy Market, By Guidance, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample